Biofourmis Supports Expansion of Remote Patient Monitoring and Introduction of Home Based Hospital Care at Lee Health

Biofourmis, a leading care delivery technology company, is collaborating with Lee Health, a prominent not-for-profit health system in Southwest Florida, to launch a groundbreaking "Hospital at Home" program and expand Lee Health's extensive remote patient monitoring (RPM) services. The Hospital at Home initiative offers hospital-level care in patients’ homes, improving patient satisfaction and outcomes by integrating resources, technology, and a dedicated care team. This program will be the first of its kind in the region. Biofourmis will support Lee Health's entire RPM service line, which has significantly reduced 30-day readmissions by 50% and currently monitors over 700 patients daily. Using Biofourmis’ advanced platform, Lee Health’s care team will continuously monitor patients via integrated tools such as vitals tracking, fall detection, and predictive analytics to identify early signs of health deterioration.

Biofourmis Unveils Digital Measure for Nocturnal Scratch and Sleep Quality in Atopic Dermatitis

Biofourmis has launched a new digital measure aimed at assessing nocturnal scratching and sleep quality in patients with atopic dermatitis (AD). This innovative solution addresses a significant symptom of AD, which affects up to 2.6% of the population, particularly worsening at night. The clinically validated tool uses machine-learning algorithms and wearable sensors to provide continuous monitoring of nighttime scratching and sleep quantity, making it applicable for AD drug development programs. This device-agnostic measure integrates with Biofourmis’ existing digital clinical trial toolkit, enhancing the user experience for trial participants. The initiative aims to provide objective evidence of treatment effectiveness, reduce bias in measurements, and expand its application to other dermatological conditions in the future.

Glooko scores $100M and appoints new CEO

Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, has secured $100 million in Series F funding and announced Mike Alvarez as the company's newly appointed CEO.  Georgian led the round with participation from Canaan, Health Catalyst Capital, and other investors and business partners. The California-based company will use the funds to scale its product expansion globally. 

Alvarez formerly held the CEO role at Qardio, a remote patient monitoring and healthcare technology company for chronic disease management. Before that, he held leadership positions at medical device maker Medtronic, pharma company Sanofi and St. Jude Medical, which was acquired by Abbott. 

Clinical ink announces GlucoseReady™

Clinical Ink has launched GlucoseReady, a comprehensive digital platform for cardiometabolic clinical trials. This GCP-compliant platform includes tools for electronic clinical outcomes (eCOA), behavioral assessments, lifestyle tracking, blood glucose monitoring (BGM), continuous glucose monitoring (CGM), digital weight scales, and actigraphy. It features unique capabilities such as triggering hypoglycemia eCOA based on BGM and CGM data and tools for tracking and preventing non-compliance. The platform is designed for therapeutic areas like diabetes, weight management, and NASH/MASH, aiming to enhance patient retention and provide real-time data visualization for sponsors.

Carevive releases a Spanish version of their remote patient monitoring workflow to reach more patients and reduce barriers to care

Carevive Systems has introduced a Spanish version of their remote symptom monitoring (RSM) workflow and PROmpt® app, aimed at enhancing cancer care for Spanish-speaking patients. This update addresses language barriers, which often lead to miscommunication and reduced care quality. By providing Spanish language support, Carevive aims to improve patient-clinician communication and health equity, benefiting the nearly 19% of Americans who are Hispanic or Latino.

Carevive Launches Native App Technology for the Carevive PROmpt® Patient Engagement Platform

Carevive Systems has launched a native app version of their PROmpt® platform, designed to enhance the monitoring and communication between cancer patients and their care teams. This new app, available on both Apple and Android devices, improves accessibility and usability, leading to better patient engagement and outcomes. The app facilitates symptom reporting from anywhere, enhances patient-care team communication, and integrates features like biometric authentication for easier logins.

Study of digital self-management service shows 50% reduction in A&E attendances for COPD

The study team evaluating the Lenus Treat: COPD Supported Self-Management Service have released early evaluation data and an economic model which indicated the service is both less costly and  more effective than standard care. The Dynamic Rose study, funded by the Small Business Research Initiative (SBRI), recruited more than 100 patients from Hull University Teaching Hospitals NHS Trust (HUTH) following an admission. Patients were then provided with a digital  service to help them to recognise and self-report their symptoms, access self-management  resources, and to directly communicate with the clinical team if there was cause for concern. In addition to the 50 per cent reduction in A&E attendance, interim results of the Dynamic Rose study also indicated a number of other benefits as a result of the Lenus Treat: COPD Supported Self Management Service. As part of an independent health economic evaluation undertaken by the York Health Economic  Consortium funded through the project, the digital support service was modelled to be more effective and £1,749 less costly than standard care, per patient per annum.

Carbon Health Acquires CGM-Enabled Virtual Diabetes Platform Steady Health

Carbon Health has acquired Steady Health, a diabetes platform utilizing continuous glucose monitoring (CGM) data for personalized care by top endocrinologists. This acquisition enhances Carbon Health's primary care model by integrating its clinic network with virtual and hardware-enabled services for a comprehensive healthcare experience. Financial terms were not disclosed. Additionally, Carbon Health appointed Myoung Cha, former Apple Health head, as Chief Strategy Officer (CSO) and President of Home-Based Care, and Nita Sommers, former Honor president, as Chief Growth Officer (CGO). Cha will expand device-enabled home care operations, including virtual care, remote monitoring, and home diagnostics, while also advancing the company's omnichannel care model. Sommers will grow Carbon Health’s services in mental health, pediatrics, and value-based offerings for employers and payers.

Health for Mankind Company Launches DIABIMETRICS™

Health for Mankind Company has launched DIABIMETRICS™, a digital health platform designed to improve diabetes management in underserved communities, available on Google Play with an upcoming Apple App Store release. DIABIMETRICS™ targets high diabetes rates among African American, Hispanic, and Native American populations, offering personalized care plans using advanced algorithms and real-time data. Key features include glucose and HbA1C monitoring, virtual coaching, culturally tailored dietary guidance, medication adherence support, remote patient monitoring, and predictive analytics for early intervention. The platform also facilitates data sharing with healthcare providers, aiming to reduce complications and healthcare costs.

Veris Health Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center

PAVmed subsidiary Veris Health has initiated a pilot program in collaboration with The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute. The program marks the first enrollment of patients on the Veris Cancer Care Platform, designed for personalized cancer care through remote patient monitoring using biologic sensors and connected devices. This platform integrates physiological data collection, symptom reporting, telehealth capabilities, and electronic health record integration. It aims to enhance cancer care by detecting complications early, reducing unplanned hospitalizations, providing longitudinal data trends, and offering data-driven risk management tools.